After three cycles of DSS administration, mice with colitis showed reduced colon length (a marker of intestinal inflammation) as well as increased levels of DAI, MDA (a measure of the colonic oxidative insult), MPO (an index of neutrophil accumulation), and inflammatory factors (IL-1β and IL-6) (Figure 6B,C,D). This evidence concerns the gene IL6 and colitis.